Shares of Nvidia Corp. climbed toward the end of trading Wednesday after a report that the Trump administration is not planning to implement artificial-intelligence rules controlling chips ...

Venture philanthropy organisation Solve FSHD has announced an investment of $3m in Armatus Bio to support the development of ARM-201, an adeno-associated virus (AAV)-delivered microRNA (miRNA) therapy ...

Brown butter has become a favorite among bakers for its ability to elevate classic chocolate chip cookies. This simple technique infuses the cookies with a rich, nutty depth of flavor that sets ...

But first, there are very practical problems to be solved, such as developing chips that can reliably host large numbers of qubits — short for quantum bits, the fundamental unit of information ...

Nvidia CEO Jensen Huang said US and China are close in the AI chip race, with China close behind. Nvidia previously said that the Trump administration plans to restrict its chip sales to China.

Tesla DOJO 2, DOJO 3 and AI5 chips are critical for Tesla to become an AI hardware company. XAI and Tesla will buy create and build millions of these chips into their data centers and the Tesla ...

Nvidia previously said that the Trump administration plans to restrict its chip sales to China. The CEO also urged an "industry-oriented energy policy" that will encourage the growth of new tech.

Apple CEO Tim Cook has said the company is “excited” to be the first customer of TSMC’s Arizona chip plants. He made the comment as the company started construction on its third US plant.

Regulus Therapeutics specializes in microRNA technology, which focuses on the kinds and amounts of proteins cell make. Its lead asset farabursen, used to treat severe renal disease autosomal ...

Despite U.S. restrictions, Huawei is developing the Ascend 910D, a powerful AI processor aiming to rival Nvidia's H100 chip. This move highlights China's resilience in the semiconductor industry ...

Excitedly they introduce us to their newest team member and Chip a robot dog Intel has worked on with Boston Dynamics takes the stage and obediently gives a bow to the audience. This could be cute ...

At the heart of the acquisition is Regulus’ farabursen, an miRNA-targeting oligonucleotide in early-stage development for rare autosomal dominant polycystic kidney disease. Novartis is buying Regulus ...